Medicines and Healthcare Products UK has updated codeine linctus, an oral solution or syrup licensed for treating dry cough in adults, as a prescription-only treatment due to abuse, dependence and dose magnitude. Will be done
Sun Drug Ventures Ltd said it will acquire a 16.33 percent stake in Surgimatix, Inc, a US-based firm for USD 3.05 million (over Rs 25 crore). Surgimatix is participated occupied with fostering an exclusive delicate tissue obsession gadget for...
WHO Member States continued to discuss proposals to revise the International Health Regulations (HRI, 2005), highlighting the importance of their work for future global security.
The new global business partnership between Boehringer Ingelheim and Slape will expand access to AI to improve the detection, diagnosis and treatment of lameness in horses. This collaboration will enable Boehringer and Sleip to offer innovative
Biocon has announced its inclusion in SandP's 2024 Sustainability Yearbook for the second consecutive year, based on SandP's 2023 Global Corporate Sustainability Assessment (CSA) of Biocon and Biocon Biologics Limited.
Technology advancements, such as continuous blood glucose monitoring (CGM), have made tracking and controlling blood sugar levels easier. This is much needed because access to robust data can help people optimize blood sugar control
The government plans to introduce a new Production Linked Investment (PLI) scheme for the pharmaceutical sector to increase the production of key chemicals to produce active pharmaceutical ingredients (APIs).
The Indian Council of Medical Research (ICMR) recently announced a series of landmark guidelines and policies to strengthen health services in various regions. From improving early diagnosis and treatment of chronic diseases
The Melanoma Research Alliance (MRA) is the biggest non-profit organization that funds research on melanoma globally. They have expressed their approval of the US Food and Drug Administration's (FDA) decision to authorize Iovance Biotherapeutics....
Fusion Pharmaceuticals Inc., a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, announced that it has entered into an exclusive worldwide license agreement with Heidelberg University
, CDSCO.jpg)
